Cynosure Inc. won regulatory nods from South Korea and China for its Smartlipo MPX and Affirm devices, respectively.

The Westford, Mass.-based cosmetic device maker’s president and CEO, Michael Davin, said the company is set to hit the market with both devices in short order, having already established direct sales forces in both countries.

Cynosure is betting that a rising tide of middle-class citizens in the Asia Pacific region will create a large consumer base for its products. The SmartLipo device uses two types of laser to melt fat during liposuction procedures; the Affirm device is a non-invasive, laser-based skin rejuvenation system.

And it’s banking on a deal it cut with consumer products giant Unilever to develop over-the-counter laser anti-wrinkle devices based on the Affirm technology.

The Asia Pacific deals come at an opportune time for Cynosure, which posted a rough second quarter that saw it plunge into the red on a 47-percent revenue slide.

Sales slipped to $20.8 million for the quarter, compared with $39.2 million during the same period last year, prompting a more than $2.3 million Q2 net loss (compared with net income of $4.7 million during the 2008 second quarter).